These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26677224)

  • 41. Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects.
    Pieper JS; Hafmans T; Veerkamp JH; van Kuppevelt TH
    Biomaterials; 2000 Mar; 21(6):581-93. PubMed ID: 10701459
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modeling large protein-glycosaminoglycan complexes using a fragment-based approach.
    Samsonov SA; Zacharias M; Chauvot de Beauchene I
    J Comput Chem; 2019 May; 40(14):1429-1439. PubMed ID: 30768805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural basis, stoichiometry, and thermodynamics of binding of the chemokines KC and MIP2 to the glycosaminoglycan heparin.
    Sepuru KM; Nagarajan B; Desai UR; Rajarathnam K
    J Biol Chem; 2018 Nov; 293(46):17817-17828. PubMed ID: 30257866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chapter 4. Interactions of chemokines with glycosaminoglycans.
    Hamel DJ; Sielaff I; Proudfoot AE; Handel TM
    Methods Enzymol; 2009; 461():71-102. PubMed ID: 19480915
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemokine CXCL7 Heterodimers: Structural Insights, CXCR2 Receptor Function, and Glycosaminoglycan Interactions.
    Brown AJ; Joseph PR; Sawant KV; Rajarathnam K
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28368308
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The glycosaminoglycan interactome 2.0.
    Vallet SD; Berthollier C; Ricard-Blum S
    Am J Physiol Cell Physiol; 2022 Jun; 322(6):C1271-C1278. PubMed ID: 35544698
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The structural investigation of glycosaminoglycan binding to CXCL12 displays distinct interaction sites.
    Panitz N; Theisgen S; Samsonov SA; Gehrcke JP; Baumann L; Bellmann-Sickert K; Köhling S; Pisabarro MT; Rademann J; Huster D; Beck-Sickinger AG
    Glycobiology; 2016 Nov; 26(11):1209-1221. PubMed ID: 27496764
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biological findings from the recent NMR-based studies of glycosaminoglycan-protein interactions.
    Pomin VH
    Glycobiology; 2014 Nov; 24(11):991-1003. PubMed ID: 24973916
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dimerization and Crowding in the Binding of Interleukin 8 to Dendritic Glycosaminoglycans as Artificial Proteoglycans.
    Dürig JN; Schulze C; Bosse M; Penk A; Huster D; Keller S; Rademann J
    Chemistry; 2024 Mar; 30(13):e202302758. PubMed ID: 38010268
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The structure of glycosaminoglycans and their interactions with proteins.
    Gandhi NS; Mancera RL
    Chem Biol Drug Des; 2008 Dec; 72(6):455-82. PubMed ID: 19090915
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Importance of basic residues and quaternary structure in the function of MIP-1 beta: CCR5 binding and cell surface sugar interactions.
    Laurence JS; Blanpain C; De Leener A; Parmentier M; LiWang PJ
    Biochemistry; 2001 Apr; 40(16):4990-9. PubMed ID: 11305915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites.
    Goger B; Halden Y; Rek A; Mösl R; Pye D; Gallagher J; Kungl AJ
    Biochemistry; 2002 Feb; 41(5):1640-6. PubMed ID: 11814358
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular Dynamics Approaches Dissect Molecular Mechanisms Underlying Methylene Blue-Glycosaminoglycan Interactions.
    Maszota-Zieleniak M; Zsila F; Samsonov SA
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atomic Details of the Interactions of Glycosaminoglycans with Amyloid-β Fibrils.
    Stewart KL; Hughes E; Yates EA; Akien GR; Huang TY; Lima MA; Rudd TR; Guerrini M; Hung SC; Radford SE; Middleton DA
    J Am Chem Soc; 2016 Jul; 138(27):8328-31. PubMed ID: 27281497
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pigment epithelium-derived factor (PEDF) binds to glycosaminoglycans: analysis of the binding site.
    Alberdi E; Hyde CC; Becerra SP
    Biochemistry; 1998 Jul; 37(30):10643-52. PubMed ID: 9692954
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural insights into biological roles of protein-glycosaminoglycan interactions.
    Raman R; Sasisekharan V; Sasisekharan R
    Chem Biol; 2005 Mar; 12(3):267-77. PubMed ID: 15797210
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heparin binding by murine recombinant prion protein leads to transient aggregation and formation of RNA-resistant species.
    Vieira TC; Reynaldo DP; Gomes MP; Almeida MS; Cordeiro Y; Silva JL
    J Am Chem Soc; 2011 Jan; 133(2):334-44. PubMed ID: 21142149
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NMR Methods for Characterization of Glycosaminoglycan-Chemokine Interactions.
    Pomin VH; Rajarathnam K
    Methods Mol Biol; 2023; 2597():143-157. PubMed ID: 36374420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of the Glycosaminoglycan Chains of Proteoglycans.
    Song Y; Zhang F; Linhardt RJ
    J Histochem Cytochem; 2021 Feb; 69(2):121-135. PubMed ID: 32623943
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NMR structural determination of unique invertebrate glycosaminoglycans endowed with medical properties.
    Pomin VH
    Carbohydr Res; 2015 Sep; 413():41-50. PubMed ID: 26083200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.